We showed that 15 high confidence IBD risk genes changed transcript usage or expression in LPS or LPS + aIL-10R stimulated MDM, while SBNO2 represented the one high confidence IBD risk gene expressed in MDM that changed transcript usage and transcript expression upon IL-10 stimulation. The gene discussed is SBNO2; the disease is inflammatory bowel disease.